Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Spotlight on topoisomerase I inhibitors

Nov. 12, 1997

DepoCyt to be reviewed by FDA advisory committee this month

Nov. 11, 1997

NCI supports R&D on antiangiogenic agents at Telios

Nov. 10, 1997

New taxoids from RPR

Nov. 10, 1997

Gensia Sicor terminates collaboration with Atrix

Nov. 7, 1997

Korean researchers describe new ginseng saponins with antitumor activity

Nov. 7, 1997

Safety of nemorubicin (daily x 3 every 28 days) evaluated in phase I trial

Nov. 6, 1997

New camptothecin analogues synthesized at U of Michigan

Nov. 5, 1997

Bristol-Myers Squibb prepares protein farnesyltransferase inhibitors

Nov. 4, 1997

Inhibition of human pancreatic cancer invasion and metastasis by serine protease inhibitor

Nov. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...